Skip to contentClarengateINTELLIGENCE
Coverage & freshness About Clarengate
Companies/05148143

Hypha Discovery Limited

Research and experimental development on biotechnology · Abingdon

ActiveUnited KingdomIncorporated 2004Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-06-30

IXBRL · 170 source facts · 28 selected values

Validation findings
XBRL valid
Reporting period
2024-07-01 to 2025-06-30
Extraction status
complete
Numeric facts
95
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_2601_05148143_20250630
Source archive
Accounts_Monthly_Data-January2026.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Registered details

05148143
Status
Active
Type
Private Limited Company
Incorporated
2004-06-08
Jurisdiction
—
Registered office
154B, BROOK DRIVE, ABINGDON, OX14 4SD, ENGLAND

Classification

1 SIC codes
72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

9 matched grants
Novel Sustainable Manufacturing Technologies For Efficient Utilisation Of Agricultural Waste Streams In A Circular Economy
EPSRC · Research Grant · 2022-06-30 – 2025-12-31 · with 24 other participants
£1,457,225
whole project
University College LondonleadAB SugarAB Sugar (British Sugar Group)Almac GroupAlmac Group LtdAutichemAutichem LtdCellinkCroda Europe LimitedCroda InternationalEco Research LtdHypha DiscoveryHypha Discovery LtdIbioicIBioIC (Industrial Biotech Innov Ctr)Ingenza LtdIngenza (United Kingdom)Johnson MattheyJohnson Matthey (United Kingdom)Pall Corporation (UK)Pall EuropeThe Welding InstituteTwi LtdUnileverUnilever UK Central Resources Limited
A globally unique 19F, 13C, 15N NMR system to enable frontier bioscience
BBSRC · Research Grant · 2021-08-14 – 2022-08-13 · with 6 other participants
£689,881
whole project
University of BristolleadBruker UK LtdCelltech Group plcGW4 AllianceHypha DiscoveryHypha Discovery LtdUniversity of Liverpool
From O to N: engineering the gap COVID-19 continuityLead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£60,357
awarded
Manipulation of partner protein expression levels in Cytochrome P450 systems by molecular and fermentation-based manipulations
EPSRC · Studentship · 2019-09-30 – 2022-09-21 · with 1 other participant
£0
whole project
University College LondonleadHypha Discovery Ltd
From O to N: engineering the gapLead
Innovate UK · Feasibility Studies · 2019-04-01 – 2020-12-31 · with 1 other participant
£330,368
awarded
Hypha Discovery Limitedlead£330,368
University College London£201,922
PolyCYPs: optimising a preclinical platform tool to reduce pharmaceutical attrition ratesLead
Innovate UK · Collaborative R&D · 2017-07-01 – 2019-09-30 · with 1 other participant
£368,818
awarded
Hypha Discovery Limitedlead£368,818
University College London£199,989
Project title: Refining oxidative enzyme systems from talented microorganisms for industrial biocatalysisLead
Innovate UK · Feasibility Studies · 2016-01-01 – 2016-12-31 · with 1 other participant
£87,412
awarded
Hypha Discovery Limitedlead£87,412
University College London£0
Microbial Enzymatic Drug Modification to Improve Treatment OutcomesLead
Innovate UK · Feasibility Studies · 2014-06-01 – 2015-08-31
£127,535
awarded
Identifying novel brain active molecules: Developing an integrated bioengineering & in silico screening platform technology (IBIS)
Innovate UK · Feasibility Studies · 2012-11-01 – 2013-09-30 · with 1 other participant
£59,635
awarded
Pharmidex Pharmaceutical Serviceslead£89,968
Hypha Discovery Limited£59,635